We are monitoring the impact of COVID-19 on Intravenous Ibuprofen Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6500
Share on
Share on

Global Intravenous Ibuprofen Market Size, Share, Trends & Growth Analysis Report – Segmented By Age Group, Indication & Region - Industry Forecasts (2020 - 2025)

Pulished: February, 2020
ID: 6500
Pages: 175

Industry Analysis

As per our report, the size of the global intravenous ibuprofen market was worth USD 6.86 billion in 2020. This figure is estimated to be growing at a CAGR of 20.0% and will reach USD 17.07 billion by 2025. 

Intravenous ibuprofen is the type of parenteral dosage form containing anti-inflammatory action that can protect from infective agents. It is a non-steroid anti-inflammatory agent which inhibits the functions of cyclooxygenase COX-1 and COX-2 enzymes that control the synthesis of prostaglandins. Ibuprofen injection is also used to reduce pain in the menstrual cycle. The Food and Drug Administration has approved caldolor ibuprofen for paediatrics as well as adult patients.

MARKET DRIVERS

The major factors driving the growth of intravenous ibuprofen market are high bioavailability with rapid action, increasing diseases like CVS, osteoarthritis, rheumatoid arthritis, cancer and headache. Easy availability of ibuprofen on over the counter across the world is enhancing market growth. Increasing awareness about rapid pain relief injections and pharmaceutical industries are focussing on the development of innovative drugs are accelerating the demand of the market. Also, the rise in the disposable income in the urban areas is levelling up the growth rate of the market.

MARKET RESTRAINTS

However, due to the side effects of intravenous ibuprofen injection in the market, and it takes a long time to introduce new products in the market are some factors hampering the Intravenous ibuprofen global market. Due to the implementation and advancement in technology as well as investing for R&D, it will foresee a growth of ibuprofen injection market. 

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Analysed

By Age Group, Indication and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

 

This research report on the Global Intravenous Ibuprofen Market has been segmented based on the age group, indication and region.

Intravenous Ibuprofen Market – By Age group          

  • Paediatrics              
  • Adults       

Based on the age group, the Adults are the significant consumer base for intravenous ibuprofen. The paediatric segment is expected to grow at a substantial rate. The Pediatrics segment is estimated to be the quickest growing segment during the forecast period. Increasing awareness about the Intravenous ibuprofen and increasing funds from the government organizations are some factors escalating market growth.

Intravenous Ibuprofen Market - By Indication           

  • Pain/inflammatory              
  • Fever         

Based on the Indication, the fever segment is projected to grow at the most significant share from 2019 to 2024. Rising incidences of chronic diseases are propelling the demand of the market.

Regional Insights

In 2019, the North America region was the most dominated and the largest market share of intravenous ibuprofen. In this region, the U.S. and Canada are estimated to remain as the highest income-producing region. The growth of this market is credited due to extensive obtainment of intravenous ibuprofen used for treating people suffering from pain and fever.

Europe intravenous ibuprofen market is estimated to grow at a CAGR value of 19.23% during the forecast period and has occupied the second largest market share. Increasing awareness among the people, particularly in adults and Soaring occurrences of heart-related disorders and cancer are significantly driving the market.

Asia-Pacific is expected to grow with the highest CAGR value during the period. Rising awareness of non-steroidal anti-inflammatory drugs and transferring tendency associated with intravenous mode of drug delivery are fuelling the growth rate of the market. The Australian region is expected to grow high with a CAGR of 14.7% during the period.

Latin America is evaluated to grow prominently during the period. Increasing occurrences of cardiovascular diseases and growing support from the government are escalating the intravenous ibuprofen market growth.

The Middle East & Africa intravenous market is expected to reach USD 1.55billion by 2024 during the period. This region is attributed due to owing factors like pain, fever, headache, toothache, back pain, and trauma.

TOP COMPANIES IN THE MARKET

Some of the major companies dominating the Global Intravenous Ibuprofen Market profiled in the report are Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi and Laboratorios Valmorca, C.A.

RECENT MARKET DEVELOPMENTS

On January 07, 2020, Cumberland, a pharmaceutical company announced new products caldolor for the treatment of acute care. The latest version of caldolor is taken directly without dilution for pain relief. Caldolor is an anti-inflammatory agent that helps to reduce mild-moderate pain.

In 2020, the Cumberland pharmaceuticals initiated the expansion of their caldolor business in the world for the treatment of coronavirus infections. The company provides support through caldolor access to the hospitals and clinic in various countries.

In 2020, Nashville pharmaceutical company might be reducing opioid use with launching new product ibuprofen in an IV bag in the market. This IV bag helps to decrease the need for the opioid analgesic drug for post-surgery.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Age group          

                                5.1.1 Introduction           

                                5.1.2 Paediatrics              

                                5.1.3 Adults       

                                5.1.4  Y-o-Y Growth Analysis, By age group          

                                5.1.5  Market Attractiveness Analysis, By age group        

                                5.1.6  Market Share Analysis, By age group          

                5.2 Indication           

                                5.2.1 Introduction           

                                5.2.2 Pain/inflammatory              

                                5.2.3 Fever         

                                5.2.4 Y-o-Y Growth Analysis, By Indication           

                                5.2.5 Market Attractiveness Analysis, By Indication         

                                5.2.6 Market Share Analysis, By Indication           

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By age group

                                                6.1.3.3 By indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By age group

                                                6.1.4.3 By indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By age group

                                                6.1.5.3 By indication

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Cumberland Pharmaceuticals Inc.                     

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Alveda Pharmaceuticals, Inc.                              

                8.3 CSL Limited                 

                8.4 Sandor Medicaids Pvt Ltd.                    

                8.5 Germin MED                              

                8.6 Grifols S.A.                  

                8.7 Harbin Gloria Pharmaceuticals Co.Ltd.                            

                8.8 Al Nabeel International Ltd.                

                8.9 Laboratorios Valmorca, C.A.                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Age group, by Indication along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Intravenous Ibuprofen  Market By Region, From 2020-2025 ( USD Billion )
  2. Global Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  3. Global Paediatric Market By Region, From 2020-2025 ( USD Billion )
  4. Global Adults Market By Region, From 2020-2025 ( USD Billion )
  5. Global Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  6. Global Pain/inflammatory Market By Region, From 2020-2025 ( USD Billion )
  7. Global Fever Market By Region, From 2020-2025 ( USD Billion )
  8. Global Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  9. Global Supermarket and hypermarkets Market By Region, From 2020-2025 ( USD Billion )
  10. Global Convenience stores Market By Region, From 2020-2025 ( USD Billion )
  11. Global Specialty stores Market By Region, From 2020-2025 ( USD Billion )
  12. Global Online sale Market By Region, From 2020-2025 ( USD Billion )
  13. North America Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  14. North America Paediatric Market By Region, From 2020-2025 ( USD Billion )
  15. North America Adults Market By Region, From 2020-2025 ( USD Billion )
  16. North America Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  17. North America Pain/inflammatory Market By Region, From 2020-2025 ( USD Billion )
  18. North America Fever Market By Region, From 2020-2025 ( USD Billion )
  19. North America Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  20. North America Supermarket and hypermarkets Market By Region, From 2020-2025 ( USD Billion )
  21. North America Convenience stores Market By Region, From 2020-2025 ( USD Billion )
  22. North America Specialty stores Market By Region, From 2020-2025 ( USD Billion )
  23. North America Online sale Market By Region, From 2020-2025 ( USD Billion )
  24. United States Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  25. United States Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  26. United States Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  27. Canada Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  28. Canada Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  29. Canada Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  30. Europe Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  31. Europe Paediatric Market By Region, From 2020-2025 ( USD Billion )
  32. Europe Adults Market By Region, From 2020-2025 ( USD Billion )
  33. Europe Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  34. Europe Pain/inflammatory Market By Region, From 2020-2025 ( USD Billion )
  35. Europe Fever Market By Region, From 2020-2025 ( USD Billion )
  36. Europe Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  37. Europe Supermarket and hypermarkets Market By Region, From 2020-2025 ( USD Billion )
  38. Europe Convenience stores Market By Region, From 2020-2025 ( USD Billion )
  39. Europe Specialty stores Market By Region, From 2020-2025 ( USD Billion )
  40. Europe Online sale Market By Region, From 2020-2025 ( USD Billion )
  41. U.K. Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  42. U.K. Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  43. U.K. Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  44. Germany Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  45. Germany Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  46. Germany Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  47. France Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  48. France Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  49. France Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  50. Italy Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  51. Italy Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  52. Italy Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  53. Spain Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  54. Spain Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  55. Spain Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  56. Asia Pacific Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  57. Asia Pacific Paediatric Market By Region, From 2020-2025 ( USD Billion )
  58. Asia Pacific Adults Market By Region, From 2020-2025 ( USD Billion )
  59. Asia Pacific Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  60. Asia Pacific Pain/inflammatory Market By Region, From 2020-2025 ( USD Billion )
  61. Asia Pacific Fever Market By Region, From 2020-2025 ( USD Billion )
  62. Asia Pacific Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  63. Asia Pacific Supermarket and hypermarkets Market By Region, From 2020-2025 ( USD Billion )
  64. Asia Pacific Convenience stores Market By Region, From 2020-2025 ( USD Billion )
  65. Asia Pacific Specialty stores Market By Region, From 2020-2025 ( USD Billion )
  66. Asia Pacific Online sale Market By Region, From 2020-2025 ( USD Billion )
  67. Japan Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  68. Japan Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  69. Japan Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  70. China Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  71. China Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  72. China Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  73. India Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  74. India Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  75. India Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  76. Australia Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  77. Australia Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  78. Australia Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  79. South Korea Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  80. South Korea Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  81. South Korea Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  82. Latin America Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  83. Latin America Paediatric Market By Region, From 2020-2025 ( USD Billion )
  84. Latin America Adults Market By Region, From 2020-2025 ( USD Billion )
  85. Latin America Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  86. Latin America Pain/inflammatory Market By Region, From 2020-2025 ( USD Billion )
  87. Latin America Fever Market By Region, From 2020-2025 ( USD Billion )
  88. Latin America Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  89. Latin America Supermarket and hypermarkets Market By Region, From 2020-2025 ( USD Billion )
  90. Latin America Convenience stores Market By Region, From 2020-2025 ( USD Billion )
  91. Latin America Specialty stores Market By Region, From 2020-2025 ( USD Billion )
  92. Latin America Online sale Market By Region, From 2020-2025 ( USD Billion )
  93. Brazil Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  94. Brazil Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  95. Brazil Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  96. Argentina Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  97. Argentina Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  98. Argentina Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  99. Mexico Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  100. Mexico Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  101. Mexico Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  102. Rest of Latin America Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  103. Rest of Latin America Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  104. Rest of Latin America Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  105. Middle East and Africa Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  106. Middle East and Africa Paediatric Market By Region, From 2020-2025 ( USD Billion )
  107. Middle East and Africa Adults Market By Region, From 2020-2025 ( USD Billion )
  108. Middle East and Africa Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  109. Middle East and Africa Pain/inflammatory Market By Region, From 2020-2025 ( USD Billion )
  110. Middle East and Africa Fever Market By Region, From 2020-2025 ( USD Billion )
  111. Middle East and Africa Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  112. Middle East and Africa Supermarket and hypermarkets Market By Region, From 2020-2025 ( USD Billion )
  113. Middle East and Africa Convenience stores Market By Region, From 2020-2025 ( USD Billion )
  114. Middle East and Africa Specialty stores Market By Region, From 2020-2025 ( USD Billion )
  115. Middle East and Africa Online sale Market By Region, From 2020-2025 ( USD Billion )
  116. Middle East Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  117. Middle East Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  118. Middle East Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )
  119. Africa Intravenous Ibuprofen  Market By Age group, From 2020-2025 ( USD Billion )
  120. Africa Intravenous Ibuprofen  Market By Indication, From 2020-2025 ( USD Billion )
  121. Africa Intravenous Ibuprofen  Market By Distribution channel, From 2020-2025 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample